ARCH Venture Management, LLC
10 holdingsFiling period: 2026-03-31Current AUM: $706.1Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | MAZE | MAZE THERAPEUTICS INC | 4.12M | $123.0M | $110.9M | 15.71% | -- | 2026-03-31 |
| 2 | RAPP | RAPPORT THERAPEUTICS INC | 3.73M | $116.7M | $152.8M | 21.64% | -- | 2026-03-31 |
| 3 | VIR | VIR BIOTECHNOLOGY INC | 12.92M | $115.7M | $111.9M | 15.84% | -- | 2026-03-31 |
| 4 | ERAS | ERASCA INC | 7.09M | $114.7M | $128.7M | 18.23% | -3,963,997 | 2026-03-31 |
| 5 | BEAM | BEAM THERAPEUTICS INC | 4.54M | $108.2M | $115.9M | 16.41% | -- | 2026-03-31 |
| 6 | LYEL | LYELL IMMUNOPHARMA INC | 3.25M | $65.1M | $42.0M | 5.95% | +488.1K | 2026-03-31 |
| 7 | GENB | GENERATE BIOMEDICINES INC | 1.94M | $24.3M | $27.2M | 3.86% | -- | 2026-03-31 |
| 8 | TXG | 10X GENOMICS INC | 217.8K | $4.6M | $10.3M | 1.46% | -519,705 | 2026-03-31 |
| 9 | GOSS | GOSSAMER BIO INC | 8.06M | $2.6M | $1.4M | 0.19% | -- | 2026-03-31 |
| 10 | QTTB | Q32 BIO INC | 320.5K | $2.1M | $5.0M | 0.71% | -- | 2026-03-31 |
← Scroll →